Ratchaphruek Hospital PCL (BKK:RPH)

Ratchaphruek Hospital PCL Income Statement

Financials in millions THB. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	1,136	1,125	1,161	1,326	1,413	799.33
Revenue Growth (YoY)	-2.90%	-3.05%	-12.49%	-6.12%	76.72%	-2.11%
Cost of Revenue	752.68	751.44	750.58	827.01	746.98	566.64
Gross Profit	382.84	373.73	410.01	499.17	665.58	232.69
Selling, General & Admin	183.84	181.22	191.46	149.5	167.72	121.58
Operating Expenses	183.84	181.22	191.46	149.5	167.72	121.58
Operating Income	199	192.51	218.55	349.67	497.86	111.11
Interest Expense	-0.56	-0.57	-2.11	-5.55	-6.69	-7.83
Interest & Investment Income	6.58	6.58	2.78	0.81	0.35	0.35
Other Non Operating Income (Expenses)	18.91	17.85	14.16	13.26	11.54	12.86
EBT Excluding Unusual Items	223.93	216.37	233.38	358.19	503.07	116.49
Pretax Income	223.93	216.37	233.38	358.19	503.07	116.49
Income Tax Expense	46.71	43.84	48.92	71.73	100.07	22.64
Net Income	177.22	172.53	184.45	286.47	402.99	93.84
Net Income to Common	177.22	172.53	184.45	286.47	402.99	93.84
Net Income Growth	-4.87%	-6.46%	-35.61%	-28.92%	329.43%	-2.67%
Shares Outstanding (Basic)	544	546	546	546	546	546
Shares Outstanding (Diluted)	544	546	546	546	546	546
Shares Change (YoY)	-0.29%	-0.01%	-	-	-	-
EPS (Basic)	0.33	0.32	0.34	0.52	0.74	0.17
EPS (Diluted)	0.33	0.32	0.34	0.52	0.74	0.17
EPS Growth	-4.60%	-6.46%	-35.61%	-28.92%	329.43%	-2.67%
Free Cash Flow	211	230.62	342.38	420.32	271.25	131.88
Free Cash Flow Per Share	0.39	0.42	0.63	0.77	0.50	0.24
Dividend Per Share	0.290	0.290	0.300	0.350	0.300	0.130
Dividend Growth	-3.33%	-3.33%	-14.29%	16.67%	130.77%	-7.14%
Gross Margin	33.72%	33.22%	35.33%	37.64%	47.12%	29.11%
Operating Margin	17.52%	17.11%	18.83%	26.37%	35.24%	13.90%
Profit Margin	15.61%	15.33%	15.89%	21.60%	28.53%	11.74%
Free Cash Flow Margin	18.58%	20.50%	29.50%	31.69%	19.20%	16.50%
EBITDA	273.74	266.91	303.46	440.29	584.49	197.85
EBITDA Margin	24.11%	23.72%	26.15%	33.20%	41.38%	24.75%
D&A For EBITDA	74.74	74.4	84.91	90.62	86.62	86.74
EBIT	199	192.51	218.55	349.67	497.86	111.11
EBIT Margin	17.52%	17.11%	18.83%	26.37%	35.24%	13.90%
Effective Tax Rate	20.86%	20.26%	20.96%	20.02%	19.89%	19.44%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.